DAVID C. STUMP, M.D. - Corporate Board Profile

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... We have entered into consulting agreements with Drs. Pearce, Stump and Wells for consulting services as described in more detail below. ... This amount reflects payments to Dr. Stump under his consulting agreement with us for consulting services performed in 2007.
2009-05-20	David C. Stump, M.D. is Executive Vice President, Research and Development, at Human Genome Sciences, Inc., a biopharmaceutical company, and has served at that company since November 1999. ... The Audit Committee is chaired by Mr. Fust, and also includes Mr. Hurwitz and Dr. Stump. ... The following table sets forth the compensation information for our non-employee directors, ... David C. Stump M.D. Fees Earned or Paid in Cash $20,000, Option Awards $48,135, All Other Compensation $6,563, Total $74,698.
2010-04-29	David C. Stump, M.D. is Executive Vice President, Research and Development, at Human Genome Sciences, Inc. Dr. Stump holds an A.B. from Earlham College and an M.D. from Indiana University. The Audit Committee includes Dr. Stump. On the date of our annual meeting of stockholders each year, each non-employee director who serves on a committee is entitled to receive an annual payment of $3,000 for service as a member on a committee. Dr. Stump's total compensation for 2009 was $49,684.
2011-04-21	David C. Stump, M.D. is Executive Vice President, Research and Development, at Human Genome Sciences, Inc., a biopharmaceutical company, and has served at that company since November 1999. ... The Audit Committee is chaired by Mr. Fust, and also includes Mr. Hurwitz and Dr. Stump. ... The following table sets forth the compensation information for our non-employee directors, as well as Dr. Young, the current Chairman of our Board and former Executive Chairman, for the year ended December 31, 2010. ... David C. Stump M.D. Fees Earned or Paid in Cash $35,000, Option Awards $5,393, Total $40,393.
2012-04-23	David C. Stump, M.D. has been Executive Vice President, Research and Development, at Human Genome Sciences, Inc. Dr. Stump has served as a consultant to Sunesis. The Board has concluded that Dr. Stump should serve on our Board due to his scientific and clinical expertise. Director Compensation Table shows total compensation of $107,690.
2013-04-25	David C. Stump, M.D. was most recently Executive Vice President, Research and Development, at Human Genome Sciences, Inc., a biopharmaceutical company, serving there from November 1999 until December 2012. ... The Audit Committee is chaired by Mr. Fust, and also includes Ms. Kim and Dr. Stump. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2012. ... David C. Stump total compensation $85,480.
2014-04-24	David C. Stump, M.D. serves on the Audit Committee. The compensation table shows total compensation of $109,796 for 2013.
2015-04-28	David C. Stump, M.D. was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., a biopharmaceutical company, serving there from November 1999 until December 2012. From December 2003 to May 2007, Dr. Stump served as Executive Vice President, Drug Development at Human Genome Sciences and, from November 1999 to December 2003, as its Senior Vice President, Drug Development. Prior to joining Human Genome Sciences, Dr. Stump held roles of increasing responsibility at Genentech, Inc., a biopharmaceutical company, from 1989 to 1999, including Vice President, Clinical Research and Genentech Fellow. Prior to joining Genentech, Dr. Stump was an Associate Professor of Medicine and Biochemistry at the University of Vermont. Dr. Stump is a member of the board of directors of Dendreon Corporation, a biotechnology company, and MacroGenics, Inc., a biopharmaceutical company, and a member of the board of trustees of Earlham College. Dr. Stump holds an A.B. from Earlham College and an M.D. from Indiana University and did his residency and fellowship training in internal medicine, hematology, oncology and biochemistry at the University of Iowa. The Board has concluded that Dr. Stump should serve on our Board due to his scientific and clinical expertise and industry background, which are valuable as we continue our drug development efforts. Director Compensation Table: David C. Stump M.D. Fees Earned or Paid in Cash ($): $50,000, Option Awards ($): $87,038, Total ($): $137,038.
2016-04-25	David C. Stump, M.D. serves on the Audit Committee. The Director Compensation Table shows total compensation of $134,652.
2017-04-20	David C. Stump, M.D. was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc. ... The Board has concluded that Dr. Stump should serve on our Board due to his scientific and clinical expertise and industry background. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. David C. Stump received total compensation of $71,740.
2018-04-25	David C. Stump, M.D. was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc. ... The Board has concluded that Dr. Stump should serve on our Board due to his scientific and clinical expertise. ... As of December 31, 2017, the Audit Committee consisted of Mr. Carchedi, Chairman, Dr. Stump and Dr. Young. ... David C. Stump 50,000 fees earned, 58,915 option awards, total 108,915.
2019-04-12	David C. Stump, M.D. was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc. ... The Board has concluded that Dr. Stump should serve on our Board due to his scientific and clinical expertise and industry background. ... Committees: Audit Committee. ... Director Compensation Table: David C. Stump M.D. Fees Earned or Paid in Cash $50,000, Option Awards $42,740, Total $92,740.
2020-04-28	David C. Stump, M.D. was Executive Vice President, Research and Development at Human Genome Sciences. The Director Compensation Table shows total compensation of $93,608 for 2019. He serves on the Audit Committee.